Skip to main content
Clinical Trials/ISRCTN43240264
ISRCTN43240264
Completed
Not Applicable

SMOKE study: evaluation of the effectiveness of an intensive SmokeStopTherapy in an outpatient clinic setting for patients with chronic obstructive pulmonary disease

etherlands Asthma Foundation (Netherlands)0 sites234 target enrollmentSeptember 12, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Other chronic obstructive pulmonary disease
Sponsor
etherlands Asthma Foundation (Netherlands)
Enrollment
234
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
etherlands Asthma Foundation (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Outpatients of Medisch Spectrum Twente (Enschede), Slotervaart hospital (Amsterdam), or Catharina hospital (Eindhoven)
  • 2\. Current smoker
  • 3\. Motivated to quit smoking
  • 4\. Aged 40 \- 75 years (1961\-1826\)
  • 5\. Clinically treated COPD. Moderate COPD (% predicted forced expiratory volume in one second \[FEV1] \= 50 \- 69\) or severe COPD (% predicted FEV1 less than or equal to 50 as defined by the American Thoracic Society (ATS) criteria

Exclusion Criteria

  • 1\. Hypersensitivity for elements of Bupropion SR
  • 2\. (Past history of) serious psychiatric co\-morbidity
  • 3\. Liver cirrhosis/alcoholism
  • 4\. (Past history of) epilepsy/fits
  • 5\. Tumour in the central nervous system
  • 6\. Quitting the use of alcohol and/or benzodiazepines during the course of the study
  • 7\. (Past history of) diabetes
  • 8\. Eating disorder(s)
  • 9\. Usage of monoamine oxidase inhibitors (MAO\-inhibitors)
  • 10\. A serious other disease with a low survival rate

Outcomes

Primary Outcomes

Not specified

Similar Trials